Anterix (ATEX) Common Equity (2016 - 2025)

Anterix filings provide 12 years of Common Equity readings, the most recent being $236.0 million for Q4 2025.

  • On a quarterly basis, Common Equity rose 63.01% to $236.0 million in Q4 2025 year-over-year; TTM through Dec 2025 was $236.0 million, a 63.01% increase, with the full-year FY2025 number at $156.6 million, down 2.75% from a year prior.
  • Common Equity hit $236.0 million in Q4 2025 for Anterix, down from $240.3 million in the prior quarter.
  • In the past five years, Common Equity ranged from a high of $240.3 million in Q3 2025 to a low of $139.1 million in Q3 2024.
  • Median Common Equity over the past 5 years was $177.9 million (2023), compared with a mean of $181.9 million.
  • Biggest five-year swings in Common Equity: fell 22.11% in 2022 and later surged 72.83% in 2025.
  • Anterix's Common Equity stood at $195.6 million in 2021, then decreased by 18.71% to $159.0 million in 2022, then grew by 8.33% to $172.3 million in 2023, then decreased by 15.97% to $144.7 million in 2024, then surged by 63.01% to $236.0 million in 2025.
  • The last three reported values for Common Equity were $236.0 million (Q4 2025), $240.3 million (Q3 2025), and $184.8 million (Q2 2025) per Business Quant data.